Clinical Trial Update: Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients With HER2-positive Unresectable or Metastatic Breast Cancer

View source ↗

Summary

Clinical trial update describing real-world treatment patterns and associated outcomes in patients with HER2-positive unresectable or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Breast Cancer | Status: COMPLETED